The finding that proTGFα could be cleaved and activated by RHBDD1 in a dose-dependent manner in the presence of TACE further supports the idea that the increased RHBDD1 expression promotes the abnormal tumor cell growth. The gene discussed is RHBDD1; the disease is neoplasm.